FDA Inspection 1169312 — University Of Texas MD Anderson Cancer Center

University Of Texas MD Anderson Cancer Center — FEI 1640006

The FDA completed an inspection of University Of Texas MD Anderson Cancer Center on May 12, 2022 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.